Inari Medical (NASDAQ:NARI) Rating Lowered to Neutral at Piper Sandler
Piper Sandler downgraded shares of Inari Medical (NASDAQ:NARI – Free Report) from an overweight rating to a neutral rating in a report published on Thursday morning, MarketBeat.com reports. Piper Sandler currently has $55.00 target price on the stock, down from their prior target price of $85.00. Other equities research analysts also recently issued reports about […]
More Stories
What is Google AI Mode? A Complete Guide to Google’s AI Search
Google AI Mode has changed the way people search nowadays. From searching to reasoning, everything is powered by artificial intelligence....
Graveyard Season 3 Updates: Release Date, Trailer, & Cast
Good News for fans of Turkish dramas and intense crime investigations! Netflix has announced that the series Graveyard season 3...
My Life with the Walter Boys Season 3 Trailer Is Out! Release Date and Ending Explained!
The wait for the most anticipated American teen drama, My Life with the Walter Boys Season 3, is coming soon....
One Hundred Years of Solitude Season 2: Release Date, Cast Members, Trailer, and More
The best-selling novel One Hundred Years of Solitude by Nobel Prize-winning Colombian author García Márquez is coming back as a...
When Your Payment Provider Can No Longer Keep Up
A payment account can work perfectly well until the business starts growing. Sales rise and customers arrive from new countries,...
The Hawk Season 2 Updates: Where Did Season 1 End
Netflix’s 2026 series, The Hawk, has been released. It has received a mixed response from the audience in different parts...